Doktor haqida
Doktor Benjamin Levi torakal tibbiy onkolog bo'lib, u Sibley Memorial kasalxonasidagi Jons Xopkins Sidney Kimmel saraton markazida tibbiy onkologiya klinik direktori va Jons Xopkins universiteti tibbiyot fakultetida onkologiya dotsenti sifatida ishlaydi. U Sibley Memorial Hospitalning Jons Xopkins Sidney Kimmel saraton markazida ishlaydi.
Dr. Levy is a clinician scientist who is interested in novel immunotherapeutic treatments for patients with advanced o'pka saratoni, as well as biomarkers that help identify those patients who are more likely to respond to such medicines. He specialises in thoracic malignancies such as non-small cell lung cancer, small cell lung cancer, thymic malignancies, and bosh va bo'yin saratoni.
Dr. Levy graduated from the Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Centre, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his Prostata saratoni clinical research. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, as the medical director of thoracic oncology for Mount Sinai Health Systems, and as the associate director of Mount Sinai Hospital’s Cancer Klinik tadqiqotlar Idora.
Doktor Levi Amerika Klinik Onkologiya Jamiyatining (ASCO) ko'plab qo'mitalarida ishlagan va hozirda ASCO Universitet qo'mitasining yordamchi muharriri. U ikki yil davomida Journal of Clinical Oncology jurnalining tahririyat kengashida ishlagan va hozirda Klinik o'pka saratoni, Onkolog va Onko maqsadi kabi qo'shimcha nashrlar uchun maxsus sharhlovchi hisoblanadi. Doktor Levi yaqinda mamlakatdagi 15 nafar onkologdan biri sifatida ASCOning bo'lajak rahbarlarini kashf etish va o'qitishga qaratilgan nufuzli ASCO Leadership Development dasturida ishtirok etish uchun tanlandi. Doktor Levi, shuningdek, ASCO faoliyatidan tashqari, ALLIANCE Respirator Qo'mitasi, IASLC Staging Qo'mitasi va IASLC Karyera rivojlantirish va Fellowship qo'mitasida xizmat qiladi.
kasalxona
Mutaxassislik
Amalga oshirilgan protseduralar
- O'pka saratoni
- immünoterapi
Tadqiqot va nashrlar
Becker DJ, Wisnivesky JP, Grossbard ML, Chachoua A, Camidge DR, Levy BP. "Tirozin kinaz inhibitörleri terapiyasi davrida rivojlangan o'pka saratoni bilan og'rigan osiyolik ayollarning omon qolishi." Klin o'pka saratoni. 2017 yil yanvar;18(1):e35-e40. doi: 10.1016/j.cllc.2016.08.008.
Levy BP, Rao P, Becker DJ, Becker K. "Harakatlanuvchi nishonga hujum qilish: tirozin kinaz inhibitörleri bilan davolangan EGFR-musbat o'pka saratoni bemorlarida qarshilikni tushunish va rivojlanishni boshqarish." Onkologiya (Uiliston bog'i). 2016 yil iyul;30(7):601-12. Ko‘rib chiqish.
Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. "Metastatik kichik hujayrali bo'lmagan o'pka saratonini davolash uchun molekulyar test: dalillarga asoslangan tavsiyalarni qanday amalga oshirish kerak." Onkolog. 2015 yil oktabr;20(10):1175-81. doi: 10.1634/teonkolog.2015-0114.
Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS . "Nivolumab, anti-PD-1 immun nazorat nuqtasi inhibitori, rivojlangan, refrakter skuamoz kichik hujayrali bo'lmagan o'pka saratoni bilan og'rigan bemorlar uchun faolligi va xavfsizligi (CheckMate 063): 2-bosqich, bir qo'l bilan sinov." Lancet Onkol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9.
Levy BP, Becker DJ. "Endi past dozali kompyuter tomografiyasi skrining vaqti: tibbiy onkolog nuqtai nazari." Onkologiya (Uiliston bog'i). 2014 yil noyabr;28(11):964-6. Annotatsiya mavjud emas.
